Table 2 Characteristics of patients with and without ocular involvement
CharacteristicsOcular involvement (n = 24)No ocular involvement (n = 726)p (2-tail)
Gender (F:M)1.9:12.3:1ns
Age at onset (years, months)<0.05
Mean5,57,4
Median4,27,0
Range0,2–14,30–16,0
JLS subtypes (%)
ECDS16 (66.7)97 (13.4)<0.001
Linear5 (20.8)373 (51.4)<0.05
Plaque1 (4.2)121 (26.3)<0.05
Generalised2 (8.3)49 (6.7)ns
Deep0 (0.0)16 (2.2)ns
Extraocular involvement (%)
Overall11 (45.8)157 (21.6)<0.01
Cardiac1 (4.2)1 (0.1)ns
Neurological6 (25)28 (3.9)<0.005
Osteoarticular2 (8.3)88 (12.1)ns
Respiratory1 (4.2)4 (0.5)ns
Vascular1 (4.2)17 (2.3)ns
Autoantibodies
ANA positive/tested (%)12/24 (50.2)272/648 (42.0)ns
RF positive/tested (%)2/10 (20.0)65/398 (16.3)ns
ACL positive/tested (%)0/5 (0.0)14/114 (12.3)ns